MTAP NEGATIVE

Clinical trials for MTAP NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new MTAP NEGATIVE trials appear

Sign up with your email to follow new studies for MTAP NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo targets Tough-to-Treat bladder cancer

Disease control Ongoing

This study is testing whether a combination of two drugs, pemetrexed and avelumab, can help control advanced bladder cancer that has spread and has a specific genetic feature (MTAP-deficient). The trial is for people whose cancer has worsened after prior treatment. Researchers wa…

Matched conditions: MTAP NEGATIVE

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

MTAP NEGATIVE

Get alerted when new MTAP NEGATIVE trials appear

New drug duo targets Tough-to-Treat bladder cancer